NervGen Pharma Corp. Common stock (NGEN) Earnings Analysis
NervGen Pharma Corp. Common stock (NGEN) next reports earnings on 2026-08-21, consensus EPS -0.09 USD. Last quarter (2026-05-18) it beat with EPS -0.01453 USD vs -0.07395 USD est (+80.4%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E -8.41.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NGEN next report earnings?
| Next earnings date | 2026-08-21 |
|---|---|
| Consensus EPS estimate | -0.09 USD |
| Revenue estimate | 0.00B |
NGEN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-18 | -0.01453 USD | -0.07395 USD | +80.4% | Beat |
| 2026-03-31 | -0.25796 USD | -0.06376 USD | -304.6% | Miss |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
NGEN valuation and analyst view
| Trailing P/E | -8.41 |
|---|---|
| Trailing EPS | -0.603 USD |
| Price / book | 108.37 |
| Dividend yield | 0.00% |
| Market cap | 0.14B |
| Analyst consensus | Buy (1 buy / 0 hold / 0 sell) |
| Avg price target | 12 USD |
Related research pages
Frequently asked questions
When is NervGen Pharma Corp. Common stock (NGEN)'s next earnings date?
NervGen Pharma Corp. Common stock is next scheduled to report on 2026-08-21, with a consensus EPS estimate of -0.09 USD and revenue estimate of 0.00B.
Did NGEN beat earnings last quarter?
In its 2026-05-18 report, NGEN posted EPS of -0.01453 USD versus a -0.07395 USD estimate — a beat of 80.4%.
What is NGEN's earnings track record?
Over the last 2 reported quarters with consensus data, NGEN beat estimates 1 times (50%).
What is NGEN's current P/E ratio and EPS?
NGEN trades at a trailing P/E of -8.41 on trailing EPS of -0.6030007791377197 USD.
What do analysts rate NGEN?
Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 12 USD.